Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 4 1Phase 3 1

Status

Unknown 3Terminated 1Completed 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Endocrine 1CNS 1

Conditions

Spinal Cord Neoplasms 1Multiple Endocrine Neoplasia Type 1 1Hemangioma, Capillary 1

Interventions

Cisplatin 509Cyclophosphamide 360Carboplatin 352Radiotherapy 350Capecitabine 329Paclitaxel 325Oxaliplatin 324Gemcitabine 319Docetaxel 311Fluorouracil 284Drug Therapy 244apatinib 242Bevacizumab 230camrelizumab 214Etoposide 200Irinotecan 177Doxorubicin 175Leucovorin 162Dexamethasone 160sintilimab 142pembrolizumab 140anlotinib 136Pemetrexed 136Cytarabine 136toripalimab 129Neoadjuvant Therapy 122S 1 (combination) 120Vincristine 119Rituximab 117Radiosurgery 117

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Unknown × Interventional × Atenolol × Clear all
NCT05106179 2021-11-03

The Efficacy and Safety of Beta-blockers Drugs in Adults With Spinal Hemangioma

Center for Vascular Pathology, Moscow

Phase 4 Unknown
1,000 enrolled
CNS

Spinal Cord Neoplasms

NCT03237637 2018-08-28

Comparative Study to Evaluate the Effectiveness of Atenolol and Propranolol in the Treatment of Infantile Hemangiomas

Post Graduate Institute of Medical Education and Research, Chandigarh

Phase 3 Unknown
60 enrolled

Hemangioma, Capillary

NCT01795235 2013-02-20

Study of Glucagon, Ghrelin and Growth Hormone as Counterregulatory Hormones

University of Virginia

Phase NA Unknown
6 enrolled
Endocrine

Multiple Endocrine Neoplasia Type 1

Data powered by HemOnc (CC BY 4.0) Colophon âš¡